COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,678 Articles (22,913 medRxiv, 8,765 bioRxiv)

Most recent first Previous |  Page 1634: Articles 16331-16340  | Next

Novel Human Lung Tissue Model for the Study of SARS-CoV-2 Entry, Inflammation and New Therapeutics
Buzon, M. J., Grau-Exposito, J., Perea, D., Suppi, M., Massana, N., Vergara, A., Soler, M. J., Garcia-Perez, J., Alcami, J., Serrano-Mollar, A., Rosado, J., Falco, V., Genesca, M.
10.1101/2021.04.21.440731 — Posted: 2021-04-23
Saliva Is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2
Callahan, C., Ditelberg, S., Dutta, S., Littlehale, N., Cheng, A., Kupczewski, K., McVay, D., Riedel, S., Kirby, J. E., Arnaout, R.
10.1101/2021.04.21.21255621 — Posted: 2021-04-23
COVID-19 vaccine hesitancy January-March 2021 among 18-64 year old US adults by employment and occupation
King, W. C., Rubinstein, M., Reinhart, A., Mejia, R. J.
10.1101/2021.04.20.21255821 — Posted: 2021-04-23 Discussion: Onsite
Model-based evaluation of alternative reactive class closure strategies against COVID-19
Liu, Q., Zhang, J., Peng, C., Litvinova, M., Huang, S., Poletti, P., Trentini, F., Guzzetta, G., Marziano, V., Zhou, T., Viboud, C., Bento, A. I., Lv, J., Vespignani, A., Merler, S., Yu, H., Ajelli, M.
10.1101/2021.04.18.21255683 — Posted: 2021-04-23
Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States
Vahidy, F. S., Pischel, L., Tano, M. E., Pan, A. P., Boom, M. L., Sostman, H. D., Nasir, K., Omer, S. B.
10.1101/2021.04.21.21255873 — Posted: 2021-04-23 Discussion: Onsite
Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK COVID-19 Infection Survey
Pritchard, E., Matthews, P., Stoesser, N., Eyre, D., Gethings, O., Vitha, K.-D., Jones, J., House, T., VanSteenhouse, H., Bell, I., Bell, J., Newton, J., Farrar, J., Diamond, I., Rourke, E., Studley, R., Crook, D. W., peto, t. E., Walker, A. S., Pouwels, K. B., Coronavirus Infection Survey team
10.1101/2021.04.22.21255913 — Posted: 2021-04-23 Discussion: Onsite
The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom
Wei, J., Stoesser, N., Matthews, P. C., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E., Pouwels, K. B., Eyre, D. W., Walker, A. S., COVID-19 Infection Survey team
10.1101/2021.04.22.21255911 — Posted: 2021-04-23
Addressing racial/ethnic disparities in the COVID-19 vaccination campaign
Reitsma, M. B., Goldhaber-Fiebert, J. D., Salomon, J. A.
10.1101/2021.04.21.21255878 — Posted: 2021-04-23
Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel
Zell, J., Lucas, C., Klein, J., Iwasaki, A., Slade, M., Liu, J., Wisnewski, A. V., Redlich, C.
10.1101/2021.04.21.21255881 — Posted: 2021-04-23
Socio-demographic and knowledge-related determinants of vitamin D supplementation in the context of the COVID-19 pandemic: assessment of an educational intervention
Zmitek, K., Hribar, M., Lavrisa, Z., Hristov, H., Kusar, A., Pravst, I.
10.1101/2021.04.21.21255553 — Posted: 2021-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).